CFHealthHub Data Observatory

Not Applicable

• Conditions: Cystic Fibrosis; Respiratory

• Registration Number: ISRCTN14464661
• Lead Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-08-02
• Last Update Posted: 15 April 2024
• Study Completion: 2025-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1. Diagnosed with CF and with data within the CF registry
2. Aged 16 years and above
3. Taking inhaled mucolytics or antibiotics via a chipped nebuliser (e.g. eTrack or I-Neb) or able and willing to take via eTrack or I-Neb

Exclusion Criteria

Lacking in capacity to give informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 11/02/2020:<br>Objective nebuliser adherence measured using adherence information stored in the CFHealthHub system. Three-monthly and annual adherence for each individual will be calculated as unadjusted adherence, normative adherence (Hoo, 2016) and total nebuliser used per week. <br><br>Previous primary outcome measure:<br>Sophisticated normative adherence as defined by Hoo (2016)